Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corvus Pharmaceuticals

2.85
-0.1400-4.68%
Post-market: 2.84-0.0100-0.35%18:48 EDT
Volume:832.26K
Turnover:2.33M
Market Cap:194.19M
PE:-2.79
High:2.97
Open:2.90
Low:2.71
Close:2.99
Loading ...
Mar 25, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Correspondence

Form CORRESP - Correspondence
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 08, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 06, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Major Issues Report

Form 8-K - Current report